Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Allarity Therapeutics Inc ALLR

Healthcare Biotechnology
Allarity Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on developing personalized cancer treatments. The Company is focused on development of stenoparib, a poly-ADP-ribose polymerase/Tankyrase inhibitor for advanced ovarian cancer patients, using its DRP companion diagnostic for patient selection in the ongoing phase 2 clinical trial, NCT03878849. It has in-licensed the... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ALLR)

Allarity Therapeutics Receives NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)(1)

GlobeNewswire 2 days ago

Allarity Therapeutics Announces 1-for-20 Reverse Stock Split

GlobeNewswire April 4, 2024

Allarity Therapeutics Makes Strategic Pivot to Focus Solely on Accelerating Stenoparib Toward Regulatory Approval in Advanced Recurrent Ovarian Cancer

GlobeNewswire March 27, 2024

Allarity Therapeutics Receives Extension from Nasdaq Hearings Panel to Regain Compliance with Listing Rules 5550(a)(2) and 5550(b)(1)

GlobeNewswire March 25, 2024

Allarity Therapeutics Reports Full Year 2023 Financial Results and Provides a Business Update

GlobeNewswire March 8, 2024

Allarity Therapeutics to Present at Biomarkers 2024

GlobeNewswire February 28, 2024

Allarity Therapeutics Announces Thomas Jensen as Interim CEO and Appointment of Jeremy R. Graff, PhD as Key Executive Advisor

GlobeNewswire December 12, 2023

Allarity's Early Phase 2 Stenoparib Data Indicates Clinical Benefit in Women with Advanced Ovarian Cancer Selected with DRP® Companion Diagnostic

GlobeNewswire December 5, 2023

Allarity Therapeutics to Present at Biomarkers Europe 2023

GlobeNewswire October 2, 2023
View More News ››

Opinion & Analysis (NDAQ:ALLR)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ALLR)

Allarity Therapeutics Inc. (NASDAQ: ALLR) Near the Top of Eq

Just In: $ALLR Allarity Therapeutics Inc. (NASDAQ: ALLR) Near the Top of Equities by Percentage Gain on 4/12Allarity Therapeutics Inc...
whytestocks - 7 days ago

ALLR ....what chit show ; )

F'king ridiculous how they let this happen I feel for the losers
Iseneschal - December 5, 2023

ALLR.....I told you right from the opening bell

this was a train wreck waiting to happen N.L.O.D............ 50 cents You've all been had....again!!!!!
Iseneschal - December 5, 2023

ALLR .... I told the Maggot what I was going to do

SH removed my post....LoL You guys can't handle the truth They can lie like a rug but I can't say squat !!!!!
Iseneschal - December 5, 2023

ALLR...ya gotta churn it to earn it to burn it

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001860657/000121390023092856/ea188467-s1a1_allarity.htm
Iseneschal - December 5, 2023

ALLR ....I lied ..... buh bye

All over but the cryin now No position
Iseneschal - December 5, 2023
View more Bullboard ››

Coelacanth Energy Inc.

Coelacanth Energy Inc.

Coelacanth Energy Inc. is a Montney-focused oil and natural gas exploration and development company, with lands located in ...
View More »